Efficacy of angiotensin receptor blockers for nocturnal blood pressure reduction: a systematic review and meta-analysis

被引:1
|
作者
Liu, Jing [1 ]
Chen, Wei [1 ]
Shao, Shihuan [1 ]
Chen, Yuanyuan [1 ]
Wang, Hongyi [1 ]
Xi, Yang [1 ]
Wang, Luyan [1 ]
机构
[1] Peking Univ Peoples Hosp, Dept Hypertens, 11 Xizhimen South St, Beijing 100044, Peoples R China
关键词
Angiotensin II AT1 receptor antagonists (ARBs); nocturnal blood pressure; hypertension; meta-analysis; MODERATE ESSENTIAL-HYPERTENSION; SERUM URIC-ACID; DOUBLE-BLIND; ANTIHYPERTENSIVE EFFICACY; CANDESARTAN CILEXETIL; OLMESARTAN MEDOXOMIL; KOREAN PATIENTS; OPEN-LABEL; 50; MG; LOSARTAN;
D O I
10.1080/07853890.2024.2362880
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundNocturnal blood pressure (BP) is correlated with an increased risk of cardiovascular events and is an important predictor of cardiovascular death in hypertensive patients.ObjectiveNocturnal BP control is of great importance for cardiovascular risk reduction. This systematic review and meta-analysis aimed to explore the efficacy of angiotensin receptor blockers (ARBs) for nocturnal BP reduction in patients with mild to moderate hypertension.MethodsPICOS design structure was used to formulate the data extraction. All statistical calculations and analyses were performed with R.ResultsSeventy-seven studies with 13,314 participants were included. The overall analysis indicated that nocturnal BP drop varied considerably among different ARBs. Allisartan (13.04 [95% CI (-18.41, -7.68)] mmHg), olmesartan (11.67 [95% CI (-14.12, -9.21)] mmHg), telmisartan (11.11 [95% CI (-12.12, -10.11)] mmHg) were associated with greater reduction in nocturnal systolic BP. In the aspect of the nocturnal-diurnal BP drop ratio, only allisartan was greater than 1. While, the variation tendency of last 4-6 h ambulatory BP was basically consistent with nocturnal BP. Additionally, allisartan showed improvement effect in the proportion of patients with dipping BP pattern.ConclusionsThis study demonstrates that for patients with mild to moderate hypertension, allisartan, olmesartan and telmisartan have more advantages in nocturnal BP reduction among the ARBs, while allisartan can reduce nighttime BP more than daytime BP and improve the dipping pattern. This meta-analysis explores the efficacy of Angiotensin II AT1 receptor antagonists (ARBs) on nocturnal blood pressure (BP) reduction in mild to moderate hypertension.The results demonstrate that for patients with mild to moderate hypertension, allisartan, olmesartan and telmisartan have more advantages in nocturnal BP reduction among the ARBs.Allisartan can reduce nighttime BP more effectively than daytime BP, which also improve the dipping pattern.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] The required step count for a reduction in blood pressure: a systematic review and meta-analysis
    Yutaka Igarashi
    Nobuhiko Akazawa
    Seiji Maeda
    Journal of Human Hypertension, 2018, 32 : 814 - 824
  • [22] Overview of telmisartan for blood pressure reduction among angiotensin II receptor blockers: A meta-analysis of head-to-head randomized trials
    Takagi, Hisato
    Mizuno, Yusuke
    Goto, Shin-nosuke
    Umemoto, Takuya
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (06) : 3051 - 3056
  • [23] The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis
    Roerecke, Michael
    Kaczorowski, Janusz
    Tobe, Sheldon W.
    Gmel, Gerrit
    Hasan, Omer S. M.
    Rehm, Juergen
    LANCET PUBLIC HEALTH, 2017, 2 (02): : E108 - E120
  • [24] The required step count for a reduction in blood pressure: a systematic review and meta-analysis
    Igarashi, Yutaka
    Akazawa, Nobuhiko
    Maeda, Seiji
    JOURNAL OF HUMAN HYPERTENSION, 2018, 32 (12) : 814 - 824
  • [25] Blood pressure levels and brain volume reduction: a systematic review and meta-analysis
    Beauchet, Olivier
    Celle, Sebastien
    Roche, Frederic
    Bartha, Robert
    Montero-Odasso, Manuel
    Allali, Gilles
    Annweiler, Cedric
    JOURNAL OF HYPERTENSION, 2013, 31 (08) : 1502 - 1516
  • [26] Effects of Blood Pressure Reduction in Mild Hypertension A Systematic Review and Meta-analysis
    Sundstrom, Johan
    Arima, Hisatomi
    Jackson, Rod
    Turnbull, Fiona
    Rahimi, Kazem
    Chalmers, John
    Woodward, Mark
    Neal, Bruce
    ANNALS OF INTERNAL MEDICINE, 2015, 162 (03) : 184 - U74
  • [27] Chronotherapy of Hypertension with Angiotensin Receptor Blockers-A Meta-Analysis of Blood Pressure Measured by Ambulatory Blood Pressure Monitoring in Randomized Trials
    Zhao, Di
    Liu, Hui
    Dong, Pingshuan
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 361 (01): : 36 - 42
  • [28] Meta-analysis of angiotensin receptor blockers: Formulary considerations
    Hilleman, D
    Lenz, T
    Wurdeman, R
    JOURNAL OF HYPERTENSION, 2000, 18 : S159 - S159
  • [29] Systematic review and meta-analysis: α-adrenergic receptor blockers in chronic prostatitis
    Deng, Wanqin
    Du, Xianqun
    Zhou, Wanzhen
    Mei, Xuefeng
    Tian, Ying
    Chen, Lan
    Xia, Yuguo
    Zhang, Ou
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (09) : 9870 - 9878
  • [30] The effect of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on progression of gastric cancer: systematic review and meta-analysis
    Mehrdad, Seyed Ali
    Mirzavi, Farshad
    Seyedi, Seyed Mohammad Reza
    Asoodeh, Ahmad
    ANTI-CANCER DRUGS, 2022, 33 (10) : 983 - 988